Literature DB >> 2175370

Renal metabolism of angiotensin I and II.

E G Erdös1, R A Skidgel.   

Abstract

The enzymatic hydrolysis of angiotensin I and II is reviewed briefly with emphasis on two enzymes, the angiotensin I converting enzyme and neutral endopeptidase 24.11. Angiotensin I is converted to angiotensin II by converting enzyme present in many tissues and highly concentrated in the human kidney and in kidney of some laboratory animals. In addition, there is mounting evidence, collected mostly in experiments in vitro, that other enzymes may be able to activate angiotensin I, for example by the stepwise release of the C-terminal His and Leu residues. Angiotensin I, instead of being activated, could be inactivated by the cleavage of its C-terminal tripeptide either by neutral endopeptidase 24.11 or by prolyl endopeptidase. Angiotensin II is cleaved by several peptidases widely distributed in the kidney. One of the products, des-Phe8-angiotensin II, is not entirely inactive as it has an effect in the CNS.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2175370

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  8 in total

Review 1.  The significance of brain aminopeptidases in the regulation of the actions of angiotensin peptides in the brain.

Authors:  Robert C Speth; Vardan T Karamyan
Journal:  Heart Fail Rev       Date:  2008-01-09       Impact factor: 4.214

2.  Angiotensinase A gene expression and enzyme activity in isolated glomeruli of diabetic rats.

Authors:  F Thaiss; G Wolf; N Assad; G Zahner; R A Stahl
Journal:  Diabetologia       Date:  1996-03       Impact factor: 10.122

3.  Natriuretic action of angiotensin(1-7).

Authors:  A M DelliPizzi; S D Hilchey; C P Bell-Quilley
Journal:  Br J Pharmacol       Date:  1994-01       Impact factor: 8.739

4.  Novel role of aminopeptidase-A in angiotensin-(1-7) metabolism post myocardial infarction.

Authors:  Mahmoud S Alghamri; Mariana Morris; J Gary Meszaros; Khalid M Elased; Nadja Grobe
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-01-24       Impact factor: 4.733

5.  Specific cleavage of synthetic renin substrate by mouse gamma-nerve growth factor.

Authors:  M Uddin; O U Beg
Journal:  J Protein Chem       Date:  1995-10

6.  Therapeutic Assessment of Combination Therapy with a Neprilysin Inhibitor and Angiotensin Type 1 Receptor Antagonist on Angiotensin II-Induced Atherosclerosis, Abdominal Aortic Aneurysms, and Hypertension.

Authors:  Yasir AlSiraj; Sean E Thatcher; Ching Ling Liang; Heba Ali; Mark Ensor; Lisa A Cassis
Journal:  J Pharmacol Exp Ther       Date:  2021-03-11       Impact factor: 4.030

7.  Renin-angiotensin system gene expression and neurodegenerative diseases.

Authors:  Benjamin Goldstein; Robert C Speth; Malav Trivedi
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2016-09-09       Impact factor: 1.636

Review 8.  Enzymatic pathways of the brain renin-angiotensin system: unsolved problems and continuing challenges.

Authors:  Vardan T Karamyan; Robert C Speth
Journal:  Regul Pept       Date:  2007-03-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.